Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Common Equity (2021 - 2025)

Biote (BTMD) has 5 years of Common Equity data on record, last reported at -$72.8 million in Q3 2025.

  • For Q3 2025, Common Equity rose 42.64% year-over-year to -$72.8 million; the TTM value through Sep 2025 reached -$72.8 million, up 42.64%, while the annual FY2024 figure was -$102.2 million, 179.65% down from the prior year.
  • Common Equity reached -$72.8 million in Q3 2025 per BTMD's latest filing, up from -$78.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $10.7 million in Q1 2022 and bottomed at -$141.5 million in Q2 2024.
  • Average Common Equity over 5 years is -$57.9 million, with a median of -$70.8 million recorded in 2022.
  • The widest YoY moves for Common Equity: up 201.52% in 2022, down 5136.29% in 2022.
  • A 5-year view of Common Equity shows it stood at $4.1 million in 2021, then plummeted by 1512.7% to -$58.3 million in 2022, then skyrocketed by 37.29% to -$36.5 million in 2023, then crashed by 179.65% to -$102.2 million in 2024, then grew by 28.82% to -$72.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were -$72.8 million in Q3 2025, -$78.8 million in Q2 2025, and -$84.8 million in Q1 2025.